| Stage | DOW | % of rev | NDAQ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.3B | 100.00% | $2.4B | 100.00% | DOW ×4.71 |
| Gross profit | $1.4B | 12.23% | $1.1B | 46.05% | NDAQ +33.8pp |
| Operating income | $741M | 6.58% | $732M | 30.59% | NDAQ +24.0pp |
| Pre-tax income | $642M | 5.70% | $701M | 29.29% | NDAQ +23.6pp |
| Net income | $525M | 4.66% | $539M | 22.52% | NDAQ +17.9pp |
| Stage | DOW | NDAQ | Gap · A − B |
|---|---|---|---|
| Revenue | $11.3B100.00% | $2.4B100.00% | DOW ×4.71 |
| Gross profit | 12.23%$1.4B | 46.05%$1.1B | NDAQ +33.8pp |
| Operating income | 6.58%$741M | 30.59%$732M | NDAQ +24.0pp |
| Pre-tax income | 5.70%$642M | 29.29%$701M | NDAQ +23.6pp |
| Net income |
| 4.66%$525M |
| 22.52%$539M |
| NDAQ +17.9pp |
No shared counterparties.